References
- Lakkireddy DR, Chung MK, Gopinathannair R, Patton KK, Gluckman TJ,
Turagam M, Cheung JW, Patel P, Sotomonte J, Lampert R, Han JK,
RajagopalanB, EckhardtL, Joglar J, Sandau KE, Olshansky B, Wan E,
Noseworthy PA, Leal M, Kaufman E, Gutierrez A, Marine JE, Wang PJ,
Russo AM. Guidance for cardiac electrophysiology during the
coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19
task force; electrophysiology section of the American College of
Cardiology; and the Electrocardiography and Arrhythmias Committee of
the Council on Clinical Cardiology, American Heart Association.
Circulation 2020;17:e233-e241.
- Varma N, Epstein AE, Irimpen A, Schweikert R, Love C, TRUST
Investigators. Efficacy and safety of automatic remote monitoring for
implantable cardioverter-defibrillator follow-up: the Lumos-T safely
reduces routine office device follow-up (TRUST) trial. Circulation
2010;122:325-332.
- Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida
JS, Aliot E, Boursier M, Bizeau O, Kacet S, ECOST trial Investigators.
A randomized study of remote follow-up of implantable cardioverter
defibrillators: safety and efficacy report of the ECOST trial. Eur
Heart J 2013;34:605-614.
- Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, CONNECT
Investigators. The CONNECT (clinical evaluation of remote notification
to reduce time to clinical decision) trial: the value of wireless
remote monitoring with automatic clinician alerts. J Am Coll Cardiol
2011;57:1181-1189.
- Parthiban N, Esterman A, Mahajan R, Twomey DJ, Pathak RK, Lau DH,
Roberts-Thomson KC, Young GD, Sanders P, Ganesan AN. Remote monitoring
of implantable cardioverter-defibrillators: a systematic review and
metaanalysis of clinical outcomes. J Am Coll Cardiol
2015;65:2591-2600.